Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Daoussis

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Seminars in Arthritis and Rheumatism|December 17, 2009
Is there a role for B-cell depletion as therapy for scleroderma? A case report and review of the literatureDimitrios Daoussis, Stamatis-Nick C Liossis, Athanassios C Tsamandas, et al.
Seminars in Arthritis and Rheumatism|February 22, 2015
Anti-TNFα treatment decreases the previously increased serum Indian Hedgehog levels in patients with ankylosing spondylitis and affects the expression of functional Hedgehog pathway target genesDimitrios Daoussis, Alexandra Filippopoulou, Stamatis-Nick Liossis, et al.
Clinical and Experimental Rheumatology|January 17, 2012
Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosisDimitrios Daoussis, Stamatis-Nick C Liossis, Athanassios C Tsamandas, et al.
Arthritis and Rheumatism|December 30, 2009
Evidence that Dkk-1 is dysfunctional in ankylosing spondylitisDimitrios Daoussis, Stamatis-Nick C Liossis, Elena E Solomou, et al.
Mediterranean Journal of Rheumatology|July 18, 2020
Immune checkpoint inhibitor-induced musculoskeletal manifestations. A multicentre prospective studyDimitrios Daoussis, Konstantinos Melissaropoulos, Theodoros Dimitroulas, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 1, 2015
Decreased Serotonin Levels and Serotonin-Mediated Osteoblastic Inhibitory Signaling in Patients With Ankylosing SpondylitisKalliopi Klavdianou, Stamatis-Nick Liossis, Dionysios J Papachristou, et al.
Arthritis Research & Therapy|July 28, 2009
Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritisDimitrios Daoussis, Vasileios Panoulas, Tracey Toms, et al.
Rheumatology (Oxford, England)|May 19, 2009
Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle studyDimitrios Daoussis, Stamatis-Nick C Liossis, Athanassios C Tsamandas, et al.
Immunologic Research|April 8, 2020
Antigen-specific humoral responses against Helicobacter pylori in patients with systemic sclerosisGeorgios Efthymiou, Christos Liaskos, Theodora Simopoulou, et al.
Rheumatology International|June 23, 2019
B cell depletion treatment decreases CD4+IL4+ and CD4+CD40L+ T cells in patients with systemic sclerosisIoannis Antonopoulos, Dimitrios Daoussis, Maria-Eleni Lalioti, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Seminars in Arthritis and Rheumatism|December 17, 2009
Is there a role for B-cell depletion as therapy for scleroderma? A case report and review of the literatureDimitrios Daoussis, Stamatis-Nick C Liossis, Athanassios C Tsamandas, et al.
Seminars in Arthritis and Rheumatism|February 22, 2015
Anti-TNFα treatment decreases the previously increased serum Indian Hedgehog levels in patients with ankylosing spondylitis and affects the expression of functional Hedgehog pathway target genesDimitrios Daoussis, Alexandra Filippopoulou, Stamatis-Nick Liossis, et al.
Clinical and Experimental Rheumatology|January 17, 2012
Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosisDimitrios Daoussis, Stamatis-Nick C Liossis, Athanassios C Tsamandas, et al.
Arthritis and Rheumatism|December 30, 2009
Evidence that Dkk-1 is dysfunctional in ankylosing spondylitisDimitrios Daoussis, Stamatis-Nick C Liossis, Elena E Solomou, et al.
Mediterranean Journal of Rheumatology|July 18, 2020
Immune checkpoint inhibitor-induced musculoskeletal manifestations. A multicentre prospective studyDimitrios Daoussis, Konstantinos Melissaropoulos, Theodoros Dimitroulas, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 1, 2015
Decreased Serotonin Levels and Serotonin-Mediated Osteoblastic Inhibitory Signaling in Patients With Ankylosing SpondylitisKalliopi Klavdianou, Stamatis-Nick Liossis, Dionysios J Papachristou, et al.
Arthritis Research & Therapy|July 28, 2009
Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritisDimitrios Daoussis, Vasileios Panoulas, Tracey Toms, et al.
Rheumatology (Oxford, England)|May 19, 2009
Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle studyDimitrios Daoussis, Stamatis-Nick C Liossis, Athanassios C Tsamandas, et al.
Immunologic Research|April 8, 2020
Antigen-specific humoral responses against Helicobacter pylori in patients with systemic sclerosisGeorgios Efthymiou, Christos Liaskos, Theodora Simopoulou, et al.
Rheumatology International|June 23, 2019
B cell depletion treatment decreases CD4+IL4+ and CD4+CD40L+ T cells in patients with systemic sclerosisIoannis Antonopoulos, Dimitrios Daoussis, Maria-Eleni Lalioti, et al.
Pageof 11